Cargando…

Sequence enrichment profiles enable target-agnostic antibody generation for a broad range of antigens

Phenotypic drug discovery (PDD) enables the target-agnostic generation of therapeutic drugs with novel mechanisms of action. However, realizing its full potential for biologics discovery requires new technologies to produce antibodies to all, a priori unknown, disease-associated biomolecules. We pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mattsson, Jenny, Ljungars, Anne, Carlsson, Anders, Svensson, Carolin, Nilsson, Björn, Ohlin, Mats, Frendéus, Björn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261905/ https://www.ncbi.nlm.nih.gov/pubmed/37323567 http://dx.doi.org/10.1016/j.crmeth.2023.100475

Ejemplares similares

Deep Mining of Complex Antibody Phage Pools Generated by Cell Panning Enables Discovery of Rare Antibodies Binding New Targets and Epitopes
por: Ljungars, Anne, et al.
Publicado: (2019)

A bispecific IgG format containing four independent antigen binding sites
por: Ljungars, Anne, et al.
Publicado: (2020)

Antigen-agnostic microfluidics-based circulating tumor cell enrichment and downstream molecular characterization
por: Cohen, Evan N., et al.
Publicado: (2020)

Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing
por: Mattsson, Jenny, et al.
Publicado: (2021)

A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia
por: Ljungars, A., et al.
Publicado: (2018)

Computational and Systems Biology Advances to Enable Bioagent-Agnostic Signatures
por: Lin, Andy, et al.
Publicado: (2023)

Quantifying Antibody Responses Induced by Antigen-Agnostic Immunotherapies
por: van Vloten, Jacob P., et al.
Publicado: (2019)

Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors
por: Borchmann, Sven, et al.
Publicado: (2022)

Function-first antibody discovery: Embracing the unpredictable biology of antibodies
por: Frendéus, Björn
Publicado: (2013)

Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies
por: van Vloten, Jacob P., et al.
Publicado: (2019)

The Bacillus Agnostic
Publicado: (1911)

Model agnostic generation of counterfactual explanations for molecules
por: Wellawatte, Geemi P., et al.
Publicado: (2022)

Agnostic Tendency in Doctors
Publicado: (1885)

Rapidly Learning Generalizable and Robot-Agnostic Tool-Use Skills for a Wide Range of Tasks
por: Qin, Meiying, et al.
Publicado: (2021)

Medical domain knowledge in domain-agnostic generative AI
por: Kather, Jakob Nikolas, et al.
Publicado: (2022)

Platform-agnostic CellNet enables cross-study analysis of cell fate engineering protocols
por: Lo, Emily K.W., et al.
Publicado: (2023)

Material-agnostic machine learning approach enables high relative density in powder bed fusion products
por: Wang, Jaemin, et al.
Publicado: (2023)

Targeting the Antibody Checkpoints to Enhance Cancer Immunotherapy–Focus on FcγRIIB
por: Teige, Ingrid, et al.
Publicado: (2019)

Tumour-agnostic drugs in paediatric cancers
por: Chisholm, Julia C., et al.
Publicado: (2020)

Drug Development in Tissue-Agnostic Indications
por: du Rusquec, Pauline, et al.
Publicado: (2021)

Simple ruthenium-catalyzed reductive amination enables the synthesis of a broad range of primary amines
por: Senthamarai, Thirusangumurugan, et al.
Publicado: (2018)

LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation
por: Yeboah, Muchaala, et al.
Publicado: (2020)

Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8(+) T cell immunity to reject ‘cold’ tumors
por: Semmrich, Monika, et al.
Publicado: (2022)

Source-Agnostic Gravitational-Wave Detection with Transformers
por: Debru, Natnael Berhane
Publicado: (2022)

Polarization- and wavelength-agnostic nanophotonic beam splitter
por: González-Andrade, David, et al.
Publicado: (2019)

Reference-agnostic representation and visualization of pan-genomes
por: Liang, Qihua, et al.
Publicado: (2021)

Technology agnostic frequency characterization methodology for memristors
por: Manouras, Vasileios, et al.
Publicado: (2021)

Crop Agnostic Monitoring Driven by Deep Learning
por: Halstead, Michael, et al.
Publicado: (2021)

PANDAA intentionally violates conventional qPCR design to enable durable, mismatch-agnostic detection of highly polymorphic pathogens
por: MacLeod, Iain J., et al.
Publicado: (2021)

Broad-Enrich: functional interpretation of large sets of broad genomic regions
por: Cavalcante, Raymond G., et al.
Publicado: (2014)

Reply to Pandey: IgG3 allotypes, modulation of antigen binding by constant domain changes, and therapeutic applications of Fc engineering
por: Izadi, Arman, et al.
Publicado: (2023)

Derivations that enable the testing of fetal urine production as a method of fetal surveillance
por: Fagerquist, Mats A., et al.
Publicado: (2009)

Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities
por: Lee, Belinda, et al.
Publicado: (2022)

Broad range of research on e-cigarettes
por: Cohen, Joanna E
Publicado: (2023)

New Physics Agnostic Selections For New Physics Searches
por: Woźniak, Kinga Anna, et al.
Publicado: (2020)

Source-Agnostic Gravitational-Wave Detection with Recurrent Autoencoders
por: Moreno, Eric A., et al.
Publicado: (2021)

Agnostic evaluation of ipilimumab and nivolumab association: a metanalysis
por: Marchetti, Paolo, et al.
Publicado: (2020)

TRK Inhibitors: Tissue-Agnostic Anti-Cancer Drugs
por: Han, Sun-Young
Publicado: (2021)

Reply to ‘Comment on “Tumour-agnostic drugs in paediatric cancers”’
por: Chisholm, Julia C., et al.
Publicado: (2020)

Precision Oncology Comes of Age: Tumor-Agnostic Approaches
por: Lewis, Colleen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uoatcsfuljfe35f30jeqn3e6dl